Tyring SK - Search Results

1

Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials.

Tyring SK, Diaz-Mitoma F, Shafran SD, Locke LA, Sacks SL, Young CL. Tyring SK, et al. J Cutan Med Surg. 2003 Nov-Dec;7(6):449-54. doi: 10.1007/s10227-002-0141-2. J Cutan Med Surg. 2003. PMID: 15931690 Clinical Trial.

2

Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.

Mark KE, Corey L, Meng TC, Magaret AS, Huang ML, Selke S, Slade HB, Tyring SK, Warren T, Sacks SL, Leone P, Bergland VA, Wald A. Mark KE, et al. Among authors: tyring sk. J Infect Dis. 2007 May 1;195(9):1324-31. doi: 10.1086/513276. Epub 2007 Mar 16. J Infect Dis. 2007. PMID: 17397003 Clinical Trial.

3

Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, Douglas JM Jr, Paavonen J, Morrow RA, Beutner KR, Stratchounsky LS, Mertz G, Keene ON, Watson HA, Tait D, Vargas-Cortes M; Valacyclovir HSV Transmission Study Group. Corey L, et al. Among authors: tyring sk. N Engl J Med. 2004 Jan 1;350(1):11-20. doi: 10.1056/NEJMoa035144. N Engl J Med. 2004. PMID: 14702423 Free article. Clinical Trial.

4

Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.

Shafran SD, Tyring SK, Ashton R, Decroix J, Forszpaniak C, Wade A, Paulet C, Candaele D. Shafran SD, et al. Among authors: tyring sk. J Clin Virol. 2004 Apr;29(4):248-53. doi: 10.1016/S1386-6532(03)00164-1. J Clin Virol. 2004. PMID: 15018852 Clinical Trial.

5

Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.

Tyring SK, Diaz-Mitoma F, Padget LG, Nunez M, Poland G, Cassidy WM, Bundick ND, Li J, Chan IS, Stek JE, Annunziato PW; Protocol 009 Study Group. Tyring SK, et al. Vaccine. 2007 Feb 26;25(10):1877-83. doi: 10.1016/j.vaccine.2006.10.027. Epub 2006 Oct 30. Vaccine. 2007. PMID: 17227688 Clinical Trial.

6

Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine.

Bernstein DI, Aoki FY, Tyring SK, Stanberry LR, St-Pierre C, Shafran SD, Leroux-Roels G, Van Herck K, Bollaerts A, Dubin G; GlaxoSmithKline Herpes Vaccine Study Group. Bernstein DI, et al. Among authors: tyring sk. Clin Infect Dis. 2005 May 1;40(9):1271-81. doi: 10.1086/429240. Epub 2005 Mar 24. Clin Infect Dis. 2005. PMID: 15825029 Clinical Trial.

7

Reduction of postherpetic neuralgia in herpes zoster.

Vander Straten M, Carrasco D, Lee P, Tyring SK. Vander Straten M, et al. Among authors: tyring sk. J Cutan Med Surg. 2001 Sep-Oct;5(5):409-16. doi: 10.1007/s102270000024. J Cutan Med Surg. 2001. PMID: 11907852 Review.

8

Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.

Wu JJ, Brentjens MH, Torres G, Yeung-Yue K, Lee P, Tyring SK. Wu JJ, et al. Among authors: tyring sk. J Cutan Med Surg. 2003 Sep-Oct;7(5):372-81. doi: 10.1007/s10227-002-0140-3. Epub 2003 Sep 24. J Cutan Med Surg. 2003. PMID: 14505192 Review.

9

Efficacy of famciclovir in the treatment of herpes zoster.

Tyring SK. Tyring SK. Semin Dermatol. 1996 Jun;15(2 Suppl 1):27-31. Semin Dermatol. 1996. PMID: 8840413 Review.

10

Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older.

Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. Tyring SK, et al. Arch Fam Med. 2000 Sep-Oct;9(9):863-9. doi: 10.1001/archfami.9.9.863. Arch Fam Med. 2000. PMID: 11031393 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

703 results

Search Page